The final analysis of a phase I/II study of nivolumab, ipilimumab combined with nintedanib in advanced non-small cell lung cancer

被引:0
|
作者
Puri, Sonam
Tanvetyanon, Tawee
Creelan, Ben C.
Shafique, Michael Rahman
Saltos, Andreas Nicholas
Chiappori, Alberto
Haura, Eric B.
Thapa, Ram
Chen, Dung-Tsa
Boyle, Theresa A.
Antonia, Scott Joseph
Gray, Jhanelle Elaine
机构
[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Duke Canc Inst, Durham, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9102
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Phase I Study of Nivolumab and Ipilimumab Combined with Nintedanib in Advanced Non-Small Cell Lung Cancer
    Puri, S.
    Guadalupe, N. Rodriguez
    Niyongere, S.
    Boyle, T.
    Thapa, R.
    Chen, D.
    Noyes, D.
    Chatwal, M.
    Antonia, S.
    Gray, J. E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S640 - S641
  • [2] Phase II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Recurrent Non-Small Cell Lung Cancer
    Puri, S.
    Tanvetyanon, T.
    Creelan, B.
    Shafique, M.
    Saltos, A.
    Chiappori, A.
    Haura, E.
    Thapa, R.
    Chen, D.
    Antonia, S.
    Gray, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S924 - S925
  • [3] Phase I/II study of nivolumab and ipilimumab combined with nintedanib in advanced NSCLC
    Puri, Sonam
    Niyongere, Sandrine
    Chatwal, Monica Sheila
    Boyle, Theresa A.
    Chen, Dung-Tsa
    Noyes, David
    Antonia, Scott Joseph
    Gray, Jhanelle Elaine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Thyroid storm induced by combined nivolumab and ipilimumab immunotherapy in advanced non-small cell lung cancer
    Kataoka, Shunichi
    Matsuno, Kei
    Sugano, Koji
    Takahashi, Kazuhisa
    BMJ CASE REPORTS, 2022, 15 (10)
  • [5] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
    Cascone, Tina
    Sepesi, Boris
    Lin, Heather Y.
    Kalhor, Neda
    Parra, Edwin R.
    Jiang, Mei
    Godoy, Myrna C. B.
    Zhang, Jianjun
    Fossella, Frank, V
    Tsao, Anne S.
    Lam, Vincent K.
    Lu, Charles
    Mott, Frank E.
    Simon, George R.
    Antonoff, Mara B.
    Mehran, Reza J.
    Rice, David C.
    Behrens, Carmen
    Weissferdt, Annikka
    Moran, Cesar
    Vaporciyan, Ara A.
    Lee, J. Jack
    Swisher, Stephen G.
    Gibbons, Don L.
    Wistuba, Ignacio I.
    William, William N., Jr.
    Heymach, John, V
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3525 - 3536
  • [7] Nivolumab for advanced non-small cell lung cancer: an evaluation of a phase III study
    Ulmeanu, Ruxandra
    Antohe, Ileana
    Anisie, Ecaterina
    Antoniu, Sabina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 165 - 167
  • [8] A Phase I Study of Enzastaurin Combined with Pemetrexed in Advanced Non-small Cell Lung Cancer
    Tanai, Chiharu
    Yamamoto, Nobuyuki
    Ohe, Yuichiro
    Takahashi, Toshiaki
    Kunitoh, Hideo
    Murakami, Haruyasu
    Yamamoto, Noboru
    Nakamura, Yukiko
    Nokihara, Hiroshi
    Shukuya, Takehito
    Baldwin, John R.
    Koshiji, Minori
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (07) : 1068 - 1074
  • [9] A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: Final report
    Pillot, Giancarlo A.
    Read, William L.
    Hennenfent, Kristin L.
    Marsh, Sharon
    Viswanathan, Avinash
    Cummings, Kristopher
    McLeod, Howard L.
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (09) : 972 - 978
  • [10] Clinical outcome of nivolumab and ipilimumab in untreated advanced non-small cell lung cancer patients
    Sugimoto, Akira
    Kaneda, Hiroyasu
    Nagamine, Hiroaki
    Nakahama, Kenji
    Ogawa, Koichi
    Matsumoto, Yoshiya
    Sawa, Kenji
    Tani, Yoko
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Kawaguchi, Tomoya
    ANNALS OF ONCOLOGY, 2023, 34 : S1451 - S1451